Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications

Abstract

TZD exposure did not increase the risk of AMI when exposure proximity was not considered. However, when evaluating exposure proximity to the event, the risk of AMI was increased with recent rosiglitazone exposure between 1 and 60 days prior to the case date.